BILL vs PYXS · rev $1.65B vs rev $2.8M
Bill Com Holdings Inc (BILL) versus Pyxis Oncology Inc (PYXS) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
BILL currently screens at market cap $4.78B. PYXS currently screens at market cap $109.6M.
Not investment advice. Open the BILL and PYXS stock pages for the full models.
Not investment advice.